Henshaw Capital’s Novartis NVS Stock Holding History

Henshaw Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Hold	12,295	–	–	0.06%	91
2026 Q1	$1.88M	Buy	12,295 +7,430	+153%	+$1.14M	0.07%	92
2025 Q4	$671K	Buy	+4,865	New	+$637K	0.02%	142
2025 Q3	–	Sell	-6,724	Closed	-$814K	–	293
2025 Q2	$814K	Hold	6,724	–	–	0.03%	172
2025 Q1	$750K	Sell	6,724 -812	-11%	-$86.4K	0.03%	171
2024 Q4	$733K	Sell	7,536 -707	-9%	-$75.4K	0.03%	154
2024 Q3	$948K	Buy	8,243 +6,269	+318%	+$711K	0.04%	133
2024 Q2	$210K	Buy	+1,974	New	+$198K	0.01%	276
2020 Q4	–	Sell	-3,537	Closed	-$308K	–	348
2020 Q3	$308K	Hold	3,537	–	–	0.02%	215
2020 Q2	$309K	Hold	3,537	–	–	0.03%	211
2020 Q1	$292K	Sell	3,537 -3,019	-46%	-$269K	0.03%	195
2019 Q4	$621K	Hold	6,556	–	–	0.05%	125
2019 Q3	$570K	Hold	6,556	–	–	0.05%	125
2019 Q2	$599K	Sell	6,556 -2,450	-27%	-$207K	0.05%	123
2019 Q1	$776K	Sell	9,006 -883	-9%	-$70.9K	0.07%	113
2018 Q4	$760K	Buy	9,889 +3,213	+48%	+$250K	0.07%	107
2018 Q3	$515K	Hold	6,676	–	–	0.04%	134
2018 Q2	$452K	Buy	6,676 +162	+2%	+$11.2K	0.04%	165
2018 Q1	$472K	Hold	6,514	–	–	0.04%	156
2017 Q4	$490K	Sell	6,514 -336	-5%	-$25.4K	0.05%	150
2017 Q3	$527K	Sell	6,850 -2,261	-25%	-$171K	0.05%	140
2017 Q2	$681K	Hold	9,111	–	–	0.07%	115
2017 Q1	$606K	Sell	9,111 -2,860	-24%	-$191K	0.07%	122
2016 Q4	$781K	Sell	11,971 -4,291	-26%	-$278K	0.09%	104
2016 Q3	$1.15M	Buy	16,262 +4,291	+36%	+$313K	0.14%	71
2016 Q2	$885K	Hold	11,971	–	–	0.12%	86
2016 Q1	$777K	Buy	+11,971	New	+$814K	0.1%	88

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Henshaw Capital's NVS Position: Q2 2026 in Review

Henshaw Capital held its Novartis (NVS) position steady in Q2 2026 at 12,295 shares worth $1.93M. The position accounts for 0.06% of the portfolio, ranked #91.

Henshaw Capital first reported a position in NVS in Q1 2016 and has held it in 27 quarters since. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Henshaw Capital held 12,295 shares of Novartis worth $1.93M as of Q2 2026.
Henshaw Capital left its Novartis share count unchanged in Q2 2026.
Novartis made up 0.06% of Henshaw Capital's portfolio in Q2 2026, its #91 holding.
Henshaw Capital first reported a position in Novartis in Q1 2016 and has held it in 27 quarters since.
1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Henshaw Capital's 13F filing for Q2 2026, filed 12 Aug 2026.